# Initial Safety Study of the TRUE AVC in Hemodialysis Access (TRUE AVC I Study)

> **NCT05567757** · PHASE1,PHASE2 · COMPLETED · sponsor: **Vascudyne, Inc.** · enrollment: 11 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **BIOLOGICAL:** Arteriovenous conduit implant

## Key facts

- **NCT ID:** NCT05567757
- **Lead sponsor:** Vascudyne, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-04
- **Primary completion:** 2025-03-30
- **Final completion:** 2025-03-30
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05567757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05567757, "Initial Safety Study of the TRUE AVC in Hemodialysis Access (TRUE AVC I Study)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05567757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*